908 Devices Inc.

General Information
Business:

We are leading a revolution in measurement devices for chemical and biochemical analysis. We are democratizing laboratory mass spectrometry instruments with our simple handheld and desktop devices, addressing critical-to-life applications. We are reimagining where Mass Spec technology can be used if it is sufficiently small in size, low in cost, and simple to operate.

We have developed an innovative suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Leveraging our proprietary platform technology, we make the extraordinary analytical power of Mass Spec available in devices that are significantly smaller and more accessible than conventional laboratory instruments. Our Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, industrial biotech, forensics and adjacent markets.

(Note: The IPO of 908 Devices (MASS) was upsized: 6.5 million shares, vs. 6.25 million shares in the prospectus, were priced at $20 each on Dec. 17 – above the increased price range of  $18 to $19. The company increased the deal’s price range on Dec. 17, 2020, from $15 to $17 initially, according to an SEC filing.)

Industry: MEASURING & CONTROLLING DEVICES
Employees: 96
Founded: 2012
Contact Information
Address 645 Summer Street, Boston, MA 02210, US
Phone Number (857) 254-1500
Web Address http://www.908devices.com
View Prospectus: 908 Devices Inc.
Financial Information
Market Cap $480.1mil
Revenues $30.9 mil (last 12 months)
Net Income $-3.2 mil (last 12 months)
IPO Profile
Symbol MASS
Exchange NASDAQ
Shares (millions): 6.5
Price range $20.00 - $20.00
Est. $ Volume $130.0 mil
Manager / Joint Managers Cowen/ SVB Leerink/ Stifel/ William Blair
CO-Managers -
Expected To Trade: 12/18/2020
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change